药物对比
Tirzepatide vs Chlorpropamide
Tirzepatide与Chlorpropamide对比：Mounjaro双重GIP/GLP-1受体激动剂与第一代磺脲类治疗2型糖尿病。比较A1c、体重、低血糖风险和安全性。
此页面暂无可用的对比维度。
临床背景
Type 2 diabetes patients considering modern weekly injectable dual-incretin therapy versus an older oral first-generation sulfonylurea.
结论
Tirzepatide generally outperforms Chlorpropamide on glucose and weight but is injectable with distinct risks, so choice depends on individual factors.
全部药物对比